Key result
Combined therapy with corticosteroids and plasma exchange resulted in survival for 3 out of 3 patients with cholesterol atheroembolic renal failure, whereas the 2 remaining patients died.
Why the study?
Does combined therapy with corticosteroids and plasma exchange improve survival and renal function in patients with cholesterol atheroembolic renal failure?
Case Report (n=5)
Does combined therapy with corticosteroids and plasma exchange improve survival and renal function in patients with cholesterol atheroembolic renal failure?
Combined therapy with corticosteroids and plasma exchange may offer survival and renal benefits in patients with cholesterol atheroembolic renal failure.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in cholesterol atheroembolic renal failure; leaves open possible benefit from combined corticosteroids and plasma exchange.
In this report, we describe 5 patients with cholesterol atheroembolic renal failure. In 3 of the 5 patients, combined therapy with corticosteroids and plasma exchange was performed. These 3 patients survived, with 2 showing an improvement in renal function. The 2 remaining patients died of multifactorial causes. The literature on therapy for cholesterol atheroembolic renal failure is reviewed and the efficacy of combined therapy by use of corticosteroids and plasma exchange is evaluated.
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (2000) conducted a case report in Cholesterol atheroembolic renal failure (n=5). Corticosteroids and plasma exchange vs. No combined therapy was evaluated on Survival and improvement in renal function. Combined therapy with corticosteroids and plasma exchange resulted in survival for 3 out of 3 patients with cholesterol atheroembolic renal failure, whereas the 2 remaining patients died.
Synapse has enriched 10 related papers. Consider them for comparative context: